ArticleJTCVS open2026
Comparison of robotic and anterolateral minithoracotomy mitral valve repair: Experience in China.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Nonsternotomy mitral valve repair is a popular treatment for degenerative mitral regurgitation. Data on the safety and effectiveness of anterolateral minithoracotomy and robotic mini-invasive mitral valve repair are lacking in China. This study compared the safety and efficacy of robotic mini-invasive and nonrobotic minithoracotomy mitral valve repair using a retrospective cohort study. Methods: We included 348 patients with degenerative mitral regurgitation who underwent robotic mini-invasive (n = 200) or anterolateral minithoracotomy mitral valve repair (n = 148) between June 2014 and January 2023. Relationships between surgical approach, surgical characteristics, and outcomes were evaluated using linear and logistic regression. Results: Among 348 patients who underwent mitral valve repair, mean age was 50.69 ± 14.13 years (63.2% men). Compared with anterolateral minithoracotomy repair, robotic mini-invasive repair had a shorter intensive care unit stay (β = -17.16; 95% confidence interval [CI], -34.18, -0.15; Conclusions: Robotic mini-invasive mitral valve repair possesses distinctive advantages and demonstrated equivalent and stable clinical efficacy compared with anterolateral minithoracotomy repair. Although not widely used in China, this approach may improve medical resource use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.